Vanta Bioscience's step-down subsidiary ties up with Emcure

Image
Press Trust of India Hyderabad
Last Updated : Apr 08 2019 | 5:30 PM IST

: Vanta Bioscience Limited Monday said its step-down subsidiary Vayam Research Solutions has entered into an agreement with Pune-based Emcure Pharmaceuticals Ltd to provide bio-analytical and bio-equivalence service for three years from now.

Managing director of Vanta Bioscience Ltd Dopesh Raja Mulakala, in a press release, said the company has state-of-the-art facility and world-class expertise to offer service on global standards.

''We're confident of delivering impeccable results and add continuously value to their business,'' the release quoted Mulakala saying.

An official of Emcure Pharmaceuticals Ltd said efficiency in service, confidentiality and belief in team in-charge of execution were the important factors for selecting the service providers for carrying out bio-analytical and bio-equivalence studies.

''We believe that Vayam has the capabilities,'' he was quoted as saying in a press release.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 08 2019 | 5:30 PM IST

Next Story